IL124060A - Process for the preparation of quinoline derivatives and intermediates in said process - Google Patents
Process for the preparation of quinoline derivatives and intermediates in said processInfo
- Publication number
- IL124060A IL124060A IL12406096A IL12406096A IL124060A IL 124060 A IL124060 A IL 124060A IL 12406096 A IL12406096 A IL 12406096A IL 12406096 A IL12406096 A IL 12406096A IL 124060 A IL124060 A IL 124060A
- Authority
- IL
- Israel
- Prior art keywords
- intermediates
- preparation
- quinoline derivatives
- quinoline
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9521004.3A GB9521004D0 (en) | 1995-10-13 | 1995-10-13 | Process |
| PCT/EP1996/004433 WO1997013753A1 (en) | 1995-10-13 | 1996-10-11 | Process for the preparation of anti-malarial drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL124060A true IL124060A (en) | 2003-07-31 |
Family
ID=10782264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12406096A IL124060A (en) | 1995-10-13 | 1996-10-11 | Process for the preparation of quinoline derivatives and intermediates in said process |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6479660B1 (xx) |
| EP (1) | EP0871616B1 (xx) |
| JP (1) | JP4083803B2 (xx) |
| KR (1) | KR100453256B1 (xx) |
| CN (1) | CN1147475C (xx) |
| AR (1) | AR004015A1 (xx) |
| AT (1) | ATE214372T1 (xx) |
| AU (1) | AU709333B2 (xx) |
| BR (1) | BR9611010A (xx) |
| CA (1) | CA2231633C (xx) |
| CZ (1) | CZ290380B6 (xx) |
| DE (1) | DE69619863T2 (xx) |
| DK (1) | DK0871616T3 (xx) |
| ES (1) | ES2170874T3 (xx) |
| GB (1) | GB9521004D0 (xx) |
| HK (1) | HK1016180A1 (xx) |
| HU (1) | HUP9900739A3 (xx) |
| IL (1) | IL124060A (xx) |
| NO (1) | NO313285B1 (xx) |
| NZ (1) | NZ320209A (xx) |
| PL (1) | PL186055B1 (xx) |
| PT (1) | PT871616E (xx) |
| SA (1) | SA97170574B1 (xx) |
| SI (1) | SI0871616T1 (xx) |
| TR (1) | TR199800637T2 (xx) |
| TW (1) | TW450950B (xx) |
| WO (1) | WO1997013753A1 (xx) |
| ZA (1) | ZA968550B (xx) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08276712A (ja) * | 1995-04-05 | 1996-10-22 | Masao Tsuji | チュ−ブレススパイクタイヤ |
| GB0210150D0 (en) * | 2002-05-03 | 2002-06-12 | Smithkline Beecham Plc | Process |
| WO2007032016A1 (en) * | 2005-09-12 | 2007-03-22 | Council Of Scientific And Industrial Research | An antimalarial baylis-hillman adducts and a process for the preparation thereof |
| WO2007127930A2 (en) * | 2006-04-28 | 2007-11-08 | Kansas State University Research Foundation | Compounds affecting gap junction activity |
| GB0620005D0 (en) | 2006-10-10 | 2006-11-22 | Glaxo Group Ltd | Compounds |
| US20090076072A1 (en) * | 2007-09-14 | 2009-03-19 | Protia, Llc | Deuterium-enriched tafenoquine |
| ES2453206B1 (es) | 2013-09-25 | 2015-01-12 | Thyssenkrupp Elevator Innovation Center, S.A. | Sistema de tracción para un sistema de transporte |
| CN113248431A (zh) * | 2021-05-21 | 2021-08-13 | 重庆医药高等专科学校 | 一种磷酸伯氨喹的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431807A (en) * | 1980-06-12 | 1984-02-14 | The United States Of America As Represented By The Secretary Of The Army | 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines |
| US4617394A (en) | 1985-10-15 | 1986-10-14 | The United States Of America As Represented By The Secretary Of The Army | 4-methyl-5-(unsubstituted and substituted phenoxy)-2,6-dimethoxy-8-(aminoalkylamino) quinolines |
-
1995
- 1995-10-13 GB GBGB9521004.3A patent/GB9521004D0/en active Pending
-
1996
- 1996-10-10 ZA ZA9608550A patent/ZA968550B/xx unknown
- 1996-10-11 AU AU72910/96A patent/AU709333B2/en not_active Ceased
- 1996-10-11 KR KR10-1998-0702696A patent/KR100453256B1/ko not_active IP Right Cessation
- 1996-10-11 US US09/051,571 patent/US6479660B1/en not_active Expired - Fee Related
- 1996-10-11 EP EP96934646A patent/EP0871616B1/en not_active Expired - Lifetime
- 1996-10-11 CA CA002231633A patent/CA2231633C/en not_active Expired - Fee Related
- 1996-10-11 PL PL96326194A patent/PL186055B1/pl not_active IP Right Cessation
- 1996-10-11 IL IL12406096A patent/IL124060A/xx not_active IP Right Cessation
- 1996-10-11 HU HU9900739A patent/HUP9900739A3/hu unknown
- 1996-10-11 WO PCT/EP1996/004433 patent/WO1997013753A1/en active IP Right Grant
- 1996-10-11 CZ CZ19981103A patent/CZ290380B6/cs not_active IP Right Cessation
- 1996-10-11 DE DE69619863T patent/DE69619863T2/de not_active Expired - Lifetime
- 1996-10-11 SI SI9630461T patent/SI0871616T1/xx unknown
- 1996-10-11 ES ES96934646T patent/ES2170874T3/es not_active Expired - Lifetime
- 1996-10-11 JP JP51471997A patent/JP4083803B2/ja not_active Expired - Fee Related
- 1996-10-11 CN CNB961975644A patent/CN1147475C/zh not_active Expired - Fee Related
- 1996-10-11 TR TR1998/00637T patent/TR199800637T2/xx unknown
- 1996-10-11 AT AT96934646T patent/ATE214372T1/de not_active IP Right Cessation
- 1996-10-11 AR ARP960104723A patent/AR004015A1/es active IP Right Grant
- 1996-10-11 DK DK96934646T patent/DK0871616T3/da active
- 1996-10-11 PT PT96934646T patent/PT871616E/pt unknown
- 1996-10-11 NZ NZ320209A patent/NZ320209A/xx not_active IP Right Cessation
- 1996-10-11 BR BR9611010A patent/BR9611010A/pt not_active Application Discontinuation
- 1996-10-14 TW TW085112489A patent/TW450950B/zh active
-
1997
- 1997-01-20 SA SA97170574A patent/SA97170574B1/ar unknown
-
1998
- 1998-04-03 NO NO19981537A patent/NO313285B1/no not_active IP Right Cessation
-
1999
- 1999-04-07 HK HK99101378A patent/HK1016180A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG25852A (en) | Teracyclic derivatives process of preparation | |
| HUP9900422A3 (en) | Novel protein and methods for the production of the same | |
| AP9901444A0 (en) | Erythrommycins and process for their preparation | |
| SG47152A1 (en) | Naphthalene derivatives process for the preparation thereof and intermediates therefor | |
| HUP9900947A3 (en) | Process for the preparation of piperidine derivatives, intermediates and preparation thereof | |
| IL113850A0 (en) | Process and intermediates for the preparation of 3-aryluracils | |
| GB9510716D0 (en) | Substituted camptothecin derivatives and process for their preparation | |
| EP0761718A3 (de) | Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden | |
| HUP9802307A3 (en) | Process for the hydrogenation of imines and for the preparation of chloro-acetanilide derivatives | |
| HUP0003614A3 (en) | Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation | |
| HUP9903701A3 (en) | Process for the preparation of 2-chlorothiazole derivatives, intermediates and preparation thereof | |
| HUP9802407A3 (en) | Process for preparing camptothecin derivatives and intermediates in their preparations | |
| HUP0003958A3 (en) | Process for preparation of 4-aryl-piperidines and intermediates | |
| HUP9600320A2 (en) | Process and new intermediates for the preparation of triazolinon-derivatives | |
| IL124060A (en) | Process for the preparation of quinoline derivatives and intermediates in said process | |
| HUP9902963A3 (en) | Process for the preparation of amino alcohols and derivatives thereof | |
| EP0761721A3 (de) | Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden | |
| IL118992A0 (en) | Process and intermediates for preparing norbenzomorphan derivatives | |
| IL125043A0 (en) | Iminooxyphenylacetic acid derivatives method and intermediates for their preparation and their use | |
| EP0761719A3 (de) | Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden | |
| EP0761720A3 (de) | Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden | |
| HU9502244D0 (en) | 3-substituted 5-quinolinecarboxylicacid-derivative and process for its preparation | |
| SG44059A1 (en) | Process for preparing acetoxyazetidinone derivative and intermediate thereof | |
| HUP9900912A3 (en) | Process for the preparation of 2-aryl-benzo[b]thiophene derivatives and their intermediates | |
| HUP9900903A3 (en) | Process for the preparation of 2-aryl-benzo[b]thiophene derivatives and their intermediates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |